Emerging Targeted Therapies for HER2-Positive Breast Cancer

por Mercogliano, María Florencia, Bruni, Sofía, Mauro, Florencia Luciana, Schillaci, Roxana
Publicado 2023

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer

por Mercogliano, María Florencia, Bruni, Sofía, Elizalde, Patricia V., Schillaci, Roxana
Publicado 2020

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy

por Mercogliano, María Florencia, Bruni, Sofía, Mauro, Florencia, Elizalde, Patricia Virginia, Schillaci, Roxana
Publicado 2021

Cancer immune exclusion: breaking the barricade for a successful immunotherapy

por Bruni, Sofia, Mercogliano, María Florencia, Mauro, Florencia Luciana, Cordo Russo, Rosalia Inés, Schillaci, Roxana
Publicado 2023

ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer

por Elizalde, Patricia, Belmonte, Martina, Cenciarini, Mauro, Deamicis, Agustina Roldan, Madera, Santiago, Mercogliano, Florencia, Mauro, Florencia, Bruni, Sofia, Russo, Rosalía Cordo, Schillaci, Roxana, Proietti, Cecilia
Publicado 2022

Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy

por De Martino, Mara, Tkach, Mercedes, Bruni, Sofía, Rocha, Darío, Mercogliano, María F., Cenciarini, Mauro E., Chervo, María F., Proietti, Cecilia J., Dingli, Florent, Loew, Damarys, Fernández, Elmer A., Elizalde, Patricia V., Piaggio, Eliane, Schillaci, Roxana
Publicado 2020

ODP551 Halting ErbB-2 Isoforms Retrograde Transport to the Nucleus as a New Theragnostic Approach for Triple Negative Breast Cancer

por Elizalde, Patricia Virginia, Izzo, Franco, Chervo, Maria Florencia, Merin, Sharon Salma, Dupont, Agustina, Chiauzzi, Violeta, Bruni, Sofia, Petrillo, Ezequiel, Montero, Diego, Mercogliano, Maria Florencia, Proietti, Cecilia Jazmin, Schillaci, Roxana, Madera, Santiago, Russo, Rosalia Ines Cordo
Publicado 2022

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer

por Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.
Publicado 2022

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

por Bruni, Sofia, Mauro, Florencia L, Proietti, Cecilia J, Cordo-Russo, Rosalia I, Rivas, Martin A, Inurrigarro, Gloria, Dupont, Agustina, Rocha, Dario, Fernández, Elmer A, Deza, Ernesto Gil, Lopez Della Vecchia, Daniel, Barchuk, Sabrina, Figurelli, Silvina, Lasso, David, Friedrich, Adrián D, Santilli, María C, Regge, María V, Lebersztein, Gabriel, Levit, Claudio, Anfuso, Fabiana, Castiglione, Teresa, Elizalde, Patricia V, Mercogliano, Maria F, Schillaci, Roxana
Publicado 2023